Literature DB >> 16474839

Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity.

S Carujo1, J M Estanyol, A Ejarque, N Agell, O Bachs, M J Pujol.   

Abstract

We report here that glyceraldehyde-3-phosphate dehydrogenase (GAPDH) interacts in vitro and in vivo with the protein SET. This interaction is performed through the acidic domain of SET located at the carboxy terminal region. On analysing the functional relevance of SET-GAPDH interaction, we observed that GAPDH reverses in a dose-dependent manner, the inhibition of cyclin B-cdk1 activity produced by SET. Similarly to SET, GAPDH associates with cyclin B, suggesting that the regulation of cyclin B-cdk1 activity might be mediated not only by the interaction of GAPDH with SET but also with cyclin B. To analyse the putative role of GAPDH on cell cycle progression, HCT116 cells were transfected with a GAPDH expression vector. Results indicate that overexpression of GAPDH does not affect the timing of DNA replication but induces an increase in the number of mitosis, an advancement of the peak of cyclin B-cdk1 activity and an acceleration of cell cycle progression. All these results suggest that GAPDH might be involved in cell cycle regulation by modulating cyclin B-cdk1 activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16474839     DOI: 10.1038/sj.onc.1209433

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

Review 1.  The diverse functions of GAPDH: views from different subcellular compartments.

Authors:  Carlos Tristan; Neelam Shahani; Thomas W Sedlak; Akira Sawa
Journal:  Cell Signal       Date:  2010-08-19       Impact factor: 4.315

2.  Metabolic control of the cell cycle.

Authors:  Joanna Kalucka; Rindert Missiaen; Maria Georgiadou; Sandra Schoors; Christian Lange; Katrien De Bock; Mieke Dewerchin; Peter Carmeliet
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment.

Authors:  Archana Mukhopadhyay; Kayann Tabanor; Rathnam Chaguturu; Jane V Aldrich
Journal:  Cancer Biol Ther       Date:  2013-08-05       Impact factor: 4.742

Review 4.  How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?

Authors:  H Lincet; P Icard
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

5.  Nuclear GAPDH: changing the fate of Müller cells in diabetes.

Authors:  Prathiba Jayaguru; Susanne Mohr
Journal:  J Ocul Biol Dis Infor       Date:  2012-03-29

6.  Cytoplastic Glyceraldehyde-3-Phosphate Dehydrogenases Interact with ATG3 to Negatively Regulate Autophagy and Immunity in Nicotiana benthamiana.

Authors:  Shaojie Han; Yan Wang; Xiyin Zheng; Qi Jia; Jinping Zhao; Fan Bai; Yiguo Hong; Yule Liu
Journal:  Plant Cell       Date:  2015-03-31       Impact factor: 11.277

7.  Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines.

Authors:  Manali S Phadke; Natalia F Krynetskaia; Anurag K Mishra; Evgeny Krynetskiy
Journal:  J Pharmacol Exp Ther       Date:  2009-07-23       Impact factor: 4.030

8.  Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage.

Authors:  Natalia F Krynetskaia; Manali S Phadke; Sachin H Jadhav; Evgeny Y Krynetskiy
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

Review 9.  Metabolic Strategies for Inhibiting Cancer Development.

Authors:  Philippe Icard; Mauro Loi; Zherui Wu; Antonin Ginguay; Hubert Lincet; Edouard Robin; Antoine Coquerel; Diana Berzan; Ludovic Fournel; Marco Alifano
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

10.  Probiotic Aspergillus oryzae produces anti-tumor mediator and exerts anti-tumor effects in pancreatic cancer through the p38 MAPK signaling pathway.

Authors:  Hiroaki Konishi; Shotaro Isozaki; Shin Kashima; Kentaro Moriichi; Satoshi Ichikawa; Kazuki Yamamoto; Chikage Yamamura; Katsuyoshi Ando; Nobuhiro Ueno; Hiroaki Akutsu; Naoki Ogawa; Mikihiro Fujiya
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.